SG166107A1 - Quadraphasic continuous graduated estrogen contraceptive - Google Patents
Quadraphasic continuous graduated estrogen contraceptiveInfo
- Publication number
- SG166107A1 SG166107A1 SG201007124-9A SG2010071249A SG166107A1 SG 166107 A1 SG166107 A1 SG 166107A1 SG 2010071249 A SG2010071249 A SG 2010071249A SG 166107 A1 SG166107 A1 SG 166107A1
- Authority
- SG
- Singapore
- Prior art keywords
- quadraphasic
- contraceptive
- estrogen contraceptive
- continuous graduated
- continuous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69509305P | 2005-06-29 | 2005-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG166107A1 true SG166107A1 (en) | 2010-11-29 |
Family
ID=37084672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201007124-9A SG166107A1 (en) | 2005-06-29 | 2006-06-29 | Quadraphasic continuous graduated estrogen contraceptive |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8461138B2 (fr) |
| EP (1) | EP1898953B1 (fr) |
| CN (1) | CN101208107A (fr) |
| CA (1) | CA2609336C (fr) |
| ES (1) | ES2399105T3 (fr) |
| IL (1) | IL187471A (fr) |
| SG (1) | SG166107A1 (fr) |
| WO (1) | WO2007002910A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124595B2 (en) * | 2003-11-14 | 2012-02-28 | Warner Chilcott Company, Llc | Graduated estrogen contraceptive |
| MX2008011074A (es) * | 2006-03-02 | 2008-09-10 | Warner Chilcott Co Inc | Metodo anticonceptivo oral multifasico de ciclo prolongado. |
| CA2856520C (fr) | 2011-11-23 | 2021-04-06 | Therapeuticsmd, Inc. | Preparations et therapies de substitution pour hormonotherapie naturelle combinee |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (fr) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne |
| CA3020153A1 (fr) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Composition pharmaceutique d'hormone steroide |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| WO2021260511A1 (fr) | 2020-06-25 | 2021-12-30 | Millicent Pharma Limited | Thérapie hormonale de substitution et/ou contraceptive multiphasique |
| CA3234836A1 (fr) | 2021-09-07 | 2023-03-16 | Millicent Pharma Limited | Regime contraceptif comprenant un niveau reduit d'oestrogene |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE35724E (en) * | 1982-04-28 | 1998-02-03 | Bio-Technology General Corp. | Contraception system and method |
| US5010070A (en) * | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
| DE4313926A1 (de) | 1993-04-28 | 1994-11-03 | Jenapharm Gmbh | Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption |
| US8124595B2 (en) | 2003-11-14 | 2012-02-28 | Warner Chilcott Company, Llc | Graduated estrogen contraceptive |
-
2006
- 2006-06-29 WO PCT/US2006/025721 patent/WO2007002910A1/fr active Application Filing
- 2006-06-29 CN CNA2006800232746A patent/CN101208107A/zh active Pending
- 2006-06-29 SG SG201007124-9A patent/SG166107A1/en unknown
- 2006-06-29 EP EP06786053A patent/EP1898953B1/fr active Active
- 2006-06-29 CA CA2609336A patent/CA2609336C/fr active Active
- 2006-06-29 US US11/476,675 patent/US8461138B2/en active Active
- 2006-06-29 ES ES06786053T patent/ES2399105T3/es active Active
-
2007
- 2007-11-19 IL IL187471A patent/IL187471A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN101208107A (zh) | 2008-06-25 |
| IL187471A (en) | 2011-11-30 |
| IL187471A0 (en) | 2008-03-20 |
| ES2399105T3 (es) | 2013-03-25 |
| WO2007002910A1 (fr) | 2007-01-04 |
| US20070004690A1 (en) | 2007-01-04 |
| EP1898953B1 (fr) | 2012-12-05 |
| CA2609336A1 (fr) | 2007-01-04 |
| EP1898953A1 (fr) | 2008-03-19 |
| CA2609336C (fr) | 2013-12-10 |
| US8461138B2 (en) | 2013-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG166107A1 (en) | Quadraphasic continuous graduated estrogen contraceptive | |
| IL174893A0 (en) | Graduated estrogen contraceptive | |
| TW200603813A (en) | Cyclic progestin regimens and kits | |
| MX2009004616A (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente. | |
| IL172959A0 (en) | Methods for contraception using estrogen and progestin | |
| MX2007004120A (es) | Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente. | |
| BRPI0512993A (pt) | uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto | |
| WO2004098517A3 (fr) | Methodes de traitement hormonal faisant appel a des schemas contraceptifs a cycle prolonge | |
| MX2009013427A (es) | Uso de estirol en bajas dosis. | |
| TW200642280A (en) | Clock synthesizer and method thereof | |
| EP1784192A4 (fr) | Compositions de creme vaginale, kits correspondants et procedes d'utilisation | |
| WO2006107953A3 (fr) | Structures d'enveloppes reutilisables et procedes associes | |
| AU306602S (en) | Chair design | |
| SI1648840T2 (sl) | Redukcijsko sredstvo za topno kromatno vsebnost v cementu in postopek za njegovo pripravo | |
| MXPA03004499A (es) | Kit de repinotan. | |
| IS2547B (is) | Efnablanda sem felur í sér samsetningu arómatasahemils, prógestíns og estrógens og notkun hennar til meðhöndlunar legslímuvillu | |
| AR042652A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
| DE602004018921D1 (de) | D dienogest | |
| AU303259S (en) | A valve cartridge for a waterless urinal | |
| AU303261S (en) | A waterless urinal | |
| AU303260S (en) | A waterless urinal | |
| GB2412867B (en) | Standardised steroid saponin mixture, a method of its obtaining and application | |
| AU302188S (en) | Spout | |
| Bridgens | Medical education in the real world. | |
| TWI315739B (en) | Modified yeasts and uses, in particular for the production of steroidal derivatives |